Mini‐Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)

I Arevalo‐Rodriguez, N Smailagic… - Cochrane database …, 2015 - cochranelibrary.com
Background Dementia is a progressive global cognitive impairment syndrome. In 2010,
more than 35 million people worldwide were estimated to be living with dementia. Some …

Mini‐Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)

I Arevalo-Rodriguez, N Smailagic… - Cochrane Database …, 2021 - cochranelibrary.com
Background Dementia is a progressive global cognitive impairment syndrome. In 2010,
more than 35 million people worldwide were estimated to be living with dementia. Some …

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

I Litvan, JG Goldman, AI Tröster… - Movement …, 2012 - Wiley Online Library
Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients
and may be a harbinger of dementia. In view of its importance, the Movement Disorder …

EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease

A Berardelli, GK Wenning, A Antonini… - European journal of …, 2013 - Wiley Online Library
Background A Task Force was convened by the EFNS/MDS‐ES Scientist Panel on P
arkinson's disease (PD) and other movement disorders to systemically review relevant …

The MoCA: well-suited screen for cognitive impairment in Parkinson disease

JC Dalrymple-Alford, MR MacAskill, CT Nakas… - Neurology, 2010 - AAN Enterprises
Objective: To establish the diagnostic accuracy of the Montreal Cognitive Assessment
(MoCA) when screening externally validated cognition in Parkinson disease (PD), by …

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

S Hoops, S Nazem, AD Siderowf, JE Duda, SX Xie… - Neurology, 2009 - AAN Enterprises
Background: Due to the high prevalence of mild cognitive impairment (MCI) and dementia in
Parkinson disease (PD), routine cognitive screening is important for the optimal …

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

P Svenningsson, E Westman, C Ballard… - The Lancet …, 2012 - thelancet.com
Dementia is one of the most common and important aspects of Parkinson's disease and has
consequences for patients and caregivers, and has health-related costs. Mild cognitive …

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis

D Aarsland, K Bronnick, C Williams-Gray, D Weintraub… - Neurology, 2010 - AAN Enterprises
Background: In studies of mild cognitive impairment (MCI) in Parkinson disease (PD),
patients without dementia have reported variable prevalences and profiles of MCI, likely to …

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

CH Williams-Gray, JR Evans, A Goris, T Foltynie… - Brain, 2009 - academic.oup.com
Cognitive abnormalities are common in Parkinson's disease, with important social and
economic implications. Factors influencing their evolution remain unclear but are crucial to …

Effects of physical exercise programs on cognitive function in Parkinson's disease patients: a systematic review of randomized controlled trials of the last 10 years

FC Da Silva, RR Iop, LC de Oliveira, AM Boll… - PloS one, 2018 - journals.plos.org
Background Given the relative importance of cognitive impairment, there was considerable
interest in identifying the cognitive profile of PD patients, in order to ensure specific and …